CloudMD Software & Services Inc. (DOCRF) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CloudMD Software & Services Inc. (DOCRF), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 38/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 16 Mar 2026CloudMD Software & Services Inc. (DOCRF) Sağlık ve Boru Hattı Genel Bakışı
CloudMD Software & Services Inc. is a North American healthcare technology company delivering digital health, clinic, and enterprise solutions. It operates through three segments, offering services like virtual care, electronic medical records, and mental health support. The company's focus is on integrating technology to enhance healthcare delivery and patient outcomes.
Yatırım Tezi
CloudMD Software & Services Inc. presents a speculative investment opportunity within the healthcare technology sector. The company's diverse service offerings, spanning digital health, clinic services, and enterprise solutions, position it to capitalize on the growing demand for integrated healthcare solutions. However, the company's negative profit margin of -91.5% raises concerns about its profitability and financial sustainability. Key growth catalysts include the expansion of its digital health services and the integration of its various platforms. Investors should closely monitor the company's ability to improve its financial performance and achieve profitability. As of March 16, 2026, the company's market capitalization is $0.01 billion, and the P/E ratio is -0.14.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- CloudMD operates through three segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions.
- The company offers MyHealthAccess, a patient portal that enables online appointment booking and virtual care visits.
- CloudMD provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores.
- The company's gross margin is 23.2%.
- CloudMD's market capitalization is $0.01 billion as of March 16, 2026.
Rakipler & Benzerleri
Güçlü Yönler
- Comprehensive suite of healthcare services.
- Integrated technology platform.
- Established network of clinics and pharmacies.
- Experienced management team.
Zayıflıklar
- Negative profit margin.
- Limited brand recognition.
- High reliance on acquisitions for growth.
- OTC market listing.
Katalizörler
- Ongoing: Expansion of digital health services and telemedicine capabilities.
- Ongoing: Integration of healthcare platforms to create a seamless patient experience.
- Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
- Ongoing: Focus on mental health solutions to capitalize on growing demand.
- Upcoming: Potential expansion into new geographic markets within the next 3-5 years.
Riskler
- Ongoing: Intense competition in the healthcare technology industry.
- Potential: Regulatory changes impacting the healthcare sector.
- Potential: Economic downturn affecting healthcare spending.
- Potential: Technological obsolescence of existing platforms.
- Ongoing: Negative profit margin and financial sustainability concerns.
Büyüme Fırsatları
- Expansion of Digital Health Services: CloudMD can capitalize on the growing demand for virtual care and remote patient monitoring by expanding its digital health services. The telemedicine market, estimated to reach $460 billion by 2030, presents a significant opportunity for CloudMD to increase its market share. By investing in its MyHealthAccess platform and telemedicine capabilities, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
- Integration of Healthcare Platforms: CloudMD can drive growth by integrating its various healthcare platforms, such as MyHealthAccess, Health and Wellness, and iMD platform, to create a seamless and comprehensive healthcare experience for patients and providers. This integration can improve patient engagement, enhance clinical outcomes, and generate valuable data insights. The integrated healthcare market is expected to grow at a CAGR of 12% over the next five years. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: CloudMD can pursue strategic partnerships and acquisitions to expand its service offerings, geographic reach, and customer base. By partnering with other healthcare providers, technology companies, and pharmaceutical companies, CloudMD can create synergistic relationships that drive growth and innovation. The company can also acquire complementary businesses to expand its market presence and gain access to new technologies. Timeline: Ongoing.
- Focus on Mental Health Solutions: CloudMD can capitalize on the growing awareness of mental health and the increasing demand for mental health services by focusing on its mental health solutions. The mental health market is estimated to reach $537.96 billion by 2030. By investing in its mental health support services and expanding its network of mental health professionals, CloudMD can attract new customers and generate recurring revenue. Timeline: Ongoing.
- Expansion into New Geographic Markets: CloudMD can expand its operations into new geographic markets, such as the United States and Europe, to increase its customer base and revenue. The global healthcare market is expected to grow at a CAGR of 5% over the next five years. By establishing a presence in new markets, CloudMD can diversify its revenue streams and reduce its reliance on the Canadian market. Timeline: Upcoming: Within the next 3-5 years.
Fırsatlar
- Expansion of digital health services.
- Strategic partnerships and acquisitions.
- Focus on mental health solutions.
- Expansion into new geographic markets.
Tehditler
- Intense competition.
- Regulatory changes.
- Economic downturn.
- Technological obsolescence.
Rekabet Avantajları
- Integrated platform offering a comprehensive suite of healthcare services.
- Established network of clinics and pharmacies.
- Proprietary technology platforms like MyHealthAccess and Health and Wellness.
- Strong relationships with healthcare providers and employers.
DOCRF Hakkında
CloudMD Software & Services Inc., established in 2013 and formerly known as Premier Health Group Inc., rebranded in February 2020 to reflect its focus on cloud-based healthcare solutions. Headquartered in Vancouver, Canada, CloudMD operates as a healthcare technology company in North America. The company is structured into three primary segments: Clinic Services & Pharmacies, Digital Health Services, and Enterprise Health Solutions. These segments provide a comprehensive suite of services, including mental health support, healthcare navigation, rehabilitation and assessments, education, absence management, and occupational health. CloudMD also offers billing and electronic medical records solutions, along with MyHealthAccess, a patient portal for online appointment booking and virtual care visits. Additionally, the company provides the Health and Wellness platform, which uses real-time data analysis to identify health indicators and compute risk scores. Other offerings include the iMD platform for educational resources, telemedicine services, and VisionPros, an online vision care platform. CloudMD operates a network of hybrid medical and rehabilitation clinics, as well as medical clinics for family practice and patient care. Its pharmacies retail prescription drugs, over-the-counter drugs, and other front store items. The company also provides patient support programs for disease management and clinical treatment outcomes, along with pharmaceutical logistic services.
Ne Yaparlar
- Provides enterprise health solutions, including mental health support and healthcare navigation.
- Offers rehabilitation and assessments, education, absence management, and occupational health services.
- Provides billing and electronic medical records solutions.
- Offers MyHealthAccess, a patient portal for online appointment booking and virtual care visits.
- Provides the Health and Wellness platform for real-time data analysis and risk score computation.
- Offers the iMD platform for peer-reviewed educational resources.
- Provides telemedicine services.
- Operates VisionPros, an online vision care platform.
İş Modeli
- Subscription fees for digital health platforms like MyHealthAccess and Health and Wellness.
- Revenue from clinic services and pharmacies, including prescription drugs and over-the-counter sales.
- Fees for enterprise health solutions, such as mental health support and healthcare navigation.
- Revenue from telemedicine services and virtual care visits.
Sektör Bağlamı
CloudMD operates within the rapidly evolving healthcare technology industry, which is experiencing significant growth due to increasing demand for digital health solutions and integrated healthcare services. The market is characterized by intense competition, with companies vying to provide innovative solutions that improve patient outcomes and reduce healthcare costs. CloudMD's focus on integrating digital health services, clinic services, and enterprise solutions positions it to capitalize on the trend towards more holistic and patient-centric care. Competitors include companies like BCBCF (WELL Health Technologies Corp.), CLSH (Clarus Therapeutics Holdings, Inc.), CRBKF (CareRx Corporation), FFLWF (Firefly Health, Inc.), and HBCNF (Helius Medical Technologies, Inc.).
Kilit Müşteriler
- Employers seeking enterprise health solutions for their employees.
- Patients seeking virtual care and online appointment booking.
- Healthcare providers using billing and electronic medical records solutions.
- Individuals seeking mental health support and healthcare navigation services.
Finansallar
Grafik & Bilgi
CloudMD Software & Services Inc. (DOCRF) hisse senedi fiyatı: Price data unavailable
Son Haberler
DOCRF için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
DOCRF için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
DOCRF için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, DOCRF'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Karen Adams
CEO
Karen Adams is the CEO of CloudMD Software & Services Inc. Her background includes extensive experience in the healthcare and technology sectors. She has held leadership positions in various companies, focusing on strategic growth, operational efficiency, and customer satisfaction. Her expertise spans across digital health solutions, healthcare services, and enterprise management. She is responsible for managing 224 employees.
Sicil: Under Karen Adams' leadership, CloudMD has focused on expanding its digital health offerings and integrating its various platforms. Key milestones include the acquisition of several companies to broaden its service portfolio and geographic reach. She has also overseen the implementation of new technologies to improve patient outcomes and enhance operational efficiency. Her tenure has been marked by a focus on innovation and strategic growth.
DOCRF OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that CloudMD Software & Services Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. This tier is generally associated with higher risk due to the potential for less transparency and liquidity.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure due to OTC Other tier status.
- Lower liquidity compared to major exchanges.
- Potential for price volatility.
- Higher risk of fraud or manipulation.
- Limited regulatory oversight.
- Verify the company's financial statements and disclosures.
- Assess the company's management team and their track record.
- Review the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Check for any red flags or warning signs.
- Consult with a financial advisor.
- Understand the risks associated with OTC trading.
- Company has been in operation since 2013.
- Operates in the healthcare technology sector, which is experiencing growth.
- Offers a range of digital health solutions and services.
- Has a network of clinics and pharmacies.
- Led by CEO Karen Adams.
DOCRF Healthcare Hisse Senedi SSS
DOCRF için değerlendirilmesi gereken temel faktörler nelerdir?
CloudMD Software & Services Inc. (DOCRF) şu anda yapay zeka skoru 38/100, düşük puanı gösteriyor. Temel güçlü yan: Comprehensive suite of healthcare services.. İzlenmesi gereken birincil risk: Ongoing: Intense competition in the healthcare technology industry.. Bu bir finansal tavsiye değildir.
DOCRF MoonshotScore'u nedir?
DOCRF şu anda MoonshotScore'da 38/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
DOCRF verileri ne sıklıkla güncellenir?
DOCRF fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler DOCRF hakkında ne diyor?
DOCRF için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
DOCRF'a yatırım yapmanın riskleri nelerdir?
DOCRF için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Ongoing: Intense competition in the healthcare technology industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
DOCRF'ın P/E oranı nedir?
DOCRF için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DOCRF'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
DOCRF aşırı değerli mi, yoksa düşük değerli mi?
CloudMD Software & Services Inc. (DOCRF)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
DOCRF'ın temettü verimi nedir?
CloudMD Software & Services Inc. (DOCRF) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Financial data is based on the most recent available information.
- AI analysis is pending and may provide additional insights.